PMA P170030S022

Device
Orsiro Sirolimus Eluting Coronary Stent System, Orsiro Mission Sirolimus Eluting Coronary Stent System
Applicant
Biotronik AG
Product code
NIQ
Decision date
2022-08-31
Generic name
Coronary drug-eluting stent
Approval order statement
Approval for the PMA Post-Approval Study Labeling Update for the Orsiro and Orsiro Mission Siolimus Eluting Coronary Stent Systems.

Current openFDA PMA Record#

Device
Orsiro Sirolimus Eluting Coronary Stent System, Orsiro Mission Sirolimus Eluting Coronary Stent System
Applicant
Biotronik AG
PMA number
P170030
Supplement
S022
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2022-08-31
Decision code
APPR
Date received
2022-03-04
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - PAS
Approval order statement
Approval for the PMA Post-Approval Study Labeling Update for the Orsiro and Orsiro Mission Siolimus Eluting Coronary Stent Systems.